| GOLDMAN SACHS GLOBAL FUTURE TECHNOLOGY LEADERS EQUITY PORTFOLIO R USD CAP | TMT | 28,68% | 58,13% | 18,80% | · |
| BANKINTER BOLSA ESPAÑA, FI R | RV ESPAÑA | 28,67% | 69,62% | 76,93% | 96,02% |
| GOLDMAN SACHS GLOBAL FUTURE TECHNOLOGY LEADERS EQUITY PORTFOLIO I USD CAP | TMT | 28,67% | 58,55% | 19,24% | · |
| ROBECO ASIA-PACIFIC EQUITIES D EUR | RVI ASIA | 28,67% | 59,37% | 56,49% | 141,50% |
| UBS (IRL) INVESTOR SELECTION - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) I-A1-ACC | RVI EMERGENTES | 28,67% | 48,75% | 10,90% | · |
| MSIF SUSTAINABLE EMERGING MARKETS EQUITY I (USD) | RVI EMERGENTES | 28,66% | 53,76% | 29,55% | 97,14% |
| ROBECO SMART MOBILITY D EUR | TMT | 28,65% | 21,10% | 21,98% | · |
| BGF US FLEXIBLE EQUITY E2 EUR (HEDGED) | RVI USA | 28,64% | 50,04% | 43,68% | 157,37% |
| FIDELITY FUNDS-PACIFIC Y-ACC-EUR | RVI ASIA | 28,64% | 40,05% | 10,93% | 103,50% |
| JPM EMERGING MARKETS EQUITY I (ACC) USD | RVI EMERGENTES | 28,64% | 36,18% | 5,96% | 127,17% |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 28,64% | 6,27% | -33,89% | · |
| UBS (IRL) INVESTOR SELECTION - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) Q-ACC | RVI EMERGENTES | 28,64% | 48,62% | 10,73% | · |
| UBS MSCI CANADA INDEX FUND USD I-B ACC | RVI USA | 28,64% | · | 83,45% | · |
| GAM MULTISTOCK EMERGING MARKETS EQUITY B CHF | RVI EMERGENTES | 28,63% | 53,32% | 14,40% | 98,08% |
| SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES B ACC EUR | RVI EMERGENTES | 28,63% | 41,15% | 17,11% | 121,85% |
| CHALLENGE ENERGY EQUITY EVOLUTION L-A | ENERGÍA | 28,61% | 53,99% | 115,86% | 78,82% |
| LA FRANÇAISE JKC ASIA EQUITY PH EUR | RVI ASIA EX-JAPÓN | 28,61% | 5,17% | -19,40% | 41,31% |
| JPM EMERGING MARKETS EQUITY C (ACC) USD | RVI EMERGENTES | 28,59% | 36,05% | 5,75% | 126,33% |
| AB FCP II-EMERGING MARKETS VALUE PORTFOLIO S1 EUR | RVI EMERGENTES | 28,58% | 53,89% | 48,83% | 118,61% |
| ALLIANZ CHINA A OPPORTUNITIES RT USD | RVI CHINA | 28,58% | 11,24% | -15,47% | · |
